Oxalic Acid

Oxalic Acid

SCHEMBL8748967

COc1ccccc1CCC(=O)NC[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CN1CCC(N2CCCCC2)CC1.O=C(O)C(=O)O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 20/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2997671 0.98 TACR1 (0.72) TACR1
SCHEMBL30307065 0.98 TACR1 (0.72) TACR1
SCHEMBL23629620 0.98 TACR1 (0.72) TACR1
Water SCHEMBL7834521 0.97 TACR1 (0.71) TACR1
Hydrochloric Acid SCHEMBL7823238 0.97 TACR1 (0.71) TACR1
Hydrochloric Acid SCHEMBL7833330 0.96 TACR1 (0.70) TACR1
SCHEMBL6763282 0.88 TACR1 (0.71) TACR1
SCHEMBL6299711 0.88 TACR1 (0.70) TACR1
SCHEMBL7035504 0.88 TACR1 (0.63) TACR1
SCHEMBL6947598 0.87 TACR1 (0.74) TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997023455-A1 PROCESSES FOR PREPARING NON-PEPTIDYL TACHYKININ RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1997-07-03 WO disclosed
EP-0761219-A1 2-Acylaminopropanamines as growth hormone secretagogues ELI LILLY AND COMPANY (US) 1997-03-12 EP disclosed
WO-1997007117-A1 2-ACYLAMINOPROPANAMINES AS GROWTH HORMONE SECRETAGOGUES ELI LILLY AND COMPANY (US) 1997-02-27 WO disclosed
WO-1996024353-A1 METHODS OF TREATING OR PREVENTING PSYCHIATRIC DISORDERS ELI LILLY AND COMPANY (US) 1996-08-15 WO disclosed